SAFE strategy

Genetic diversity of urogenital Chlamydia trachomatis before and after mass drug administration for trachoma

The WHO recommends the treatment of trachoma with community-wide MDA with a single dose of azithromycin as part of the SAFE strategy. In the Solomon Islands, this program had demonstrable collateral benefit by reducing the prevalence of urogenital Chlamydia trachomatis(Ct) infections. This study evaluated the impact of this treatment on population genetics of urogenital Ct.


Subscribe to RSS - SAFE strategy